Livzon Pharmaceutical Group Inc. Livzon Pharmaceutical Group Inc.

Livzon Pharmaceutical Group Inc.

000513

株式のランク #4689
Livzon Pharmaceutical Group Inc., headquartered in Zhuhai, China, and... Livzon Pharmaceutical Group Inc., headquartered in Zhuhai, China, and established in 1985, is a biopharmaceutical enterprise operating across the entire spectrum of pharmaceutical activities, from research and development to manufacturing and commercialization. The company's operations encompass a diverse range of finished drug products, active pharmaceutical ingredients (APIs), and chemical intermediates, primarily serving the Chinese market while also engaging in international exports. Its pharmaceutical portfolio includes treatments such as Ilaprazole enteric coated tablets for duodenal ulcers and reflux esophagitis, Laprazole sodium injection for managing peptic ulcer bleeding, Leuprorelin Acetate Microspheres for injection, and Urofollitropin injection for anovulation and fertility support. Livzon also produces Perospirone Hydrochloride for schizophrenia, Anti-viral Granules targeting upper respiratory tract infections and influenza, and Shenqi Fuzheng Injection, which addresses general weakness, fatigue, spontaneous sweating, and vertigo, and provides supportive care for lung and stomach cancer patients. Beyond therapeutic drugs, Livzon Pharmaceutical Group develops and distributes a variety of diagnostic reagents. These include kits for detecting IgM/IgG antibodies to coronavirus, nucleic acid tests for human immunodeficiency virus type 1, antinuclear antibody test kits, interferon-gamma release assay kits, and rapid tests for mycoplasma pneumoniae IgM antibodies. The company's extensive offerings further extend to biochemical drugs, microbiological preparations, biologics, traditional Chinese medicine formulations, pharmaceutical raw materials, and antibiotics.
株価
$3.90
時価総額
$3.17B
変化(1日)
-3.49%
変化(1年)
-25.88%
国
CN
取引 Livzon Pharmaceutical Group Inc. (000513)

カテゴリー

Healthcare
Livzon Pharmaceutical Group Inc.(000513)の株式分割履歴
Livzon Pharmaceutical Group Inc.株(シンボル:000513)は合計で7回の株式分割を実施しました。
最新の株式分割はJul 03, 2019に行われました。
May 26, 1994より前に購入された000513株は、現在5.07664834677000513株に相当します。
株式分割一覧
年 株式分割 分割比率 累積分割比率
2019-07-03 13:10 x1.3 x5.07664834677
2018-06-22 13:10 x1.3 x3.9051141129
2017-07-07 13:10 x1.3 x3.003933933
2015-08-14 13:10 x1.3 x2.31071841
2006-12-11 11:10 x1.1 x1.7774757
1997-09-04 124299:100000 x1.24299 x1.615887
1994-05-26 13:10 x1.3 x1.3
類似企業または競合他社の株式分割